Product
SCM-010
1 clinical trial
1 indication
Indication
Secondary Progressive Multiple SclerosisClinical trial
A Prospective, Single Center, Open Label, Dose Escalation Phase I/IIa Study to Assess the Safety and Efficacy of an Intrathecal Administration of SCM-010 in Subjects With Secondary Progressive Multiple Sclerosis (SPMS)Status: Withdrawn, Estimated PCD: 2025-02-01